首页 / 专利库 / 农用化学品和农药 / 植物病原体 / Bleomycin and processes for the preparation thereof

Bleomycin and processes for the preparation thereof

阅读:489发布:2022-09-24

专利汇可以提供Bleomycin and processes for the preparation thereof专利检索,专利查询,专利分析的服务。并且An antibiotic complex designated bleomycin was produced by fermentation of Streptomyces verticillus A.T.C.C. 15003 and found to inhibit the growth of Gram-negative and Gram-positive and acid-fast bacteria as well as certain plant pathogens and to inhibit the growth of HeLa cells in tissue culture and to inhibit the growth of certain experimental tumors in mice.,下面是Bleomycin and processes for the preparation thereof专利的具体信息内容。

  • 2. The process of producing a biologically active complex, identified as bleomycin A, which comprises cultivating Streptomyces verticillus ATTC 15933 at a temperature of about 25* C. to 35* C. for at least 2 days under submerged aerobic conditions in an aqueous assimilable carbohydrate solution containing an assimilable nitrogenous nutrient until the substantial amount of the said antibiotic is produced and then recovering from the broth the bleomycin A thus produced by adsorption on a cation exchange resin and subsequent elution therefrom and then separating the bleomycin A from the bleOmycin B present therewith by chromatography, said bleomycin A being the fraction which exhibits an Rf value of 0.88- 0.94 by paper chromatography using 10% NH4Cl.
  • 3. A biologically active complex identified as bleomycin A which is prepared by the process of claim 2 and which inhibits Gram-positive and Gram-negative bacteria, inhibits Ehrlich carcinoma, is soluble in water and methanol, and practically insoluble in ethanol, butanol, acetone, ethyl acetate, chloroform and benzene, forms salts with acids, chelates with copper, shows two ultraviolet absorption maxima at 254 m Mu and 295 m Mu , gives positive Pauly, Ehrlich, Dragendorf tests, gives negative Sakaguchi, Fehling, Tollens and Molisch tests and shows Rf 0.88-0.94 by paper chromatography using 10% NH5Cl.
  • 4. The process of producing a biologically active substance identified as bleomycin A2 which is one of the main active components of bleomycin A and which gives a negative ninhydrin reaction, gives positive Pauly, Ehrlich, Dragendorf and permanganate tests and negative Sakaguchi, Fehling, Tollens, ferric chloride and Molisch tests, contains C, H. N, S and O and exhibits the ultraviolet absorption spectrum shown in FIG. 3 and the infrared absorption spectrum shown in FIG. 4 after is has been purified as its copper-containing form designated Cu- At2 in said Figures, said process comprising cultivating Streptomyces verticillus ATTC 15003 at a temperature of about 25* C. to 35* C. for at least two days under submerged aerobic conditions in an aqueous assimilable carbohydrate solution containing an assimilable nitrogeneous nutrient until the substantial amount of the said antibiotic is produced and then recovering from the broth the bleomycin A2 thus produced by adsorption on a cation exchange resin and subsequent elution therefrom and then separating the bleomycin A2 from the other bleomycins present therewith by chromatography as the fraction which exhibits in its copper-containing from an Rf of about 0.40 in thin layer chromotography using silica gel and 10 percent ammonium acetate-methanol (1:1) and a negative Sakaguchi reaction.
  • 5. A biologically active substance identified as bleomycin A2 which is prepared by the process of claim 4 and which gives a negative ninhydrin reaction, gives positive Pauly, Ehrlich, Dragendorf and permanganate tests and negative Sakaguchi, Fehling, Tollens, ferric chloride and Molisch tests, contains C, H, N, S and O and exhibits the ultraviolet absorption spectrum shown in FIG. 3 and the infrared absorption spectrum shown in FIG. 4 after it has been purified as its copper-containing form designated Cu-At2 in said Figures.
  • 6. The process of producing a biologically active substance identified as bleomycin A5 in its copper-free form and as Cu- At5 in its copper-containing form which is one of the main components of bleomycin A and which gives a positive ninhydrin reaction, and gives positive Pauly, Ehrlich, Dragendorf and permanganate tests and negative Sakaguchi, Fehling, Tollens, ferric chloride and Mollisch tests, and exhibits the ultraviolet absorption spectrum shown in FIG. 3 and the infrared absorption spectrum shown in FIG. 4 after it has been purified as its copper-containing form designated Cu- At5 in said FIgures, said process comprising cultivating Streptomyces verticillus ATCC 15003 at a temperature of about 25* C. to 35* C. for at least two days under submerged aerobic conditions in an aqueous assimilable carbohydrate solution containing an assimilable nitrogenous nutrient until the substantial amount of the said antibiotic is produced and then recovering from the broth the bleomycin A5 thus produced by adsorption on a cation exchange resin and subsequent elution therefrom And then separating the bleomycin A5 from the other bleomycins present therewith by chromatography as the fraction which exhibits in its copper-containing form an Rf of about 0.51 in thin layer chromotography using silica gel and 10 percent ammonium acetate-methanol (1.1) and a negative Sakaguchi reaction.
  • 7. A biologically active substance identified as bleomycin A5 in its copper-free form and as Cu- At5 4 l in its copper-containing form which is prepared by the process of claim 6 and which gives a positive ninhydrin reaction, and gives positive Pauly, Ehrlich, Dragendorf and permanganate tests and negative Sakaguchi, Fehling, Tollens, ferric chloride and Molisch tests, and exhibits the ultraviolet absorption spectrum shown in FIG. 3 and the infrared absorption spectrum shown in FIG. 4 after it has been purified as its copper-containing form designated Cu- At5 in said Figures.
  • 说明书全文
    高效检索全球专利

    专利汇是专利免费检索,专利查询,专利分析-国家发明专利查询检索分析平台,是提供专利分析,专利查询,专利检索等数据服务功能的知识产权数据服务商。

    我们的产品包含105个国家的1.26亿组数据,免费查、免费专利分析。

    申请试用

    分析报告

    专利汇分析报告产品可以对行业情报数据进行梳理分析,涉及维度包括行业专利基本状况分析、地域分析、技术分析、发明人分析、申请人分析、专利权人分析、失效分析、核心专利分析、法律分析、研发重点分析、企业专利处境分析、技术处境分析、专利寿命分析、企业定位分析、引证分析等超过60个分析角度,系统通过AI智能系统对图表进行解读,只需1分钟,一键生成行业专利分析报告。

    申请试用

    QQ群二维码
    意见反馈